Last reviewed · How we verify
Prostatitis
Approved treatments
- Cefradex · Bristol-Myers Squibb
- Ciprofloxacine · Poitiers University Hospital
- Keflex · Shionogi
- Noroxin
- Floxin
- Carboxybenzylpenicillin
- Cipro · Bayer AG
- Cephradin · Sohag University
- Ofloxacine · Assistance Publique - Hôpitaux de Paris
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Prostatitis patent landscape — cliff calendar, originator estates, attackable patents
- Prostatitis treatment landscape brief
- Prostatitis treatment updates RSS
Frequently asked questions about Prostatitis
What drugs treat Prostatitis?
Tracked treatments include Cefradex, Ciprofloxacine, Keflex, Noroxin, Floxin, Carboxybenzylpenicillin, Cipro, Cephradin.
What is the treatment for Prostatitis?
Standard treatment for Prostatitis includes Cefradex, Ciprofloxacine, Keflex, Noroxin, Floxin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Prostatitis patent cliff · Prostatitis CI report
- Treatment: Cefradex · Bristol-Myers Squibb
- Treatment: Ciprofloxacine · Poitiers University Hospital
- Treatment: Keflex · Shionogi
- Treatment: Noroxin
- Treatment: Floxin
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing